Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-...

por Kato, Jitsu, Matsui, Norimitsu, Kakehi, Yoshihiro, Murayama, Emiko, Ohwada, Shoichi
Publicado 2020

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients

por Kato, Jitsu, Matsui, Norimitsu, Kakehi, Yoshihiro, Murayama, Emiko, Ohwada, Shoichi, Sugihara, Masahiro
Publicado 2019

Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia

por Ushida, Takahiro, Katayama, Yoichi, Hiasa, Yoichi, Nishihara, Makoto, Tajima, Fumihiro, Katoh, Shinsuke, Tanaka, Hirotaka, Maeda, Takeshi, Furusawa, Kazunari, Kakehi, Yoshihiro, Kikumori, Kunika, Kuroha, Masanori
Publicado 2023

Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia

por Ushida, Takahiro, Katayama, Yoichi, Hiasa, Yoichi, Nishihara, Makoto, Tajima, Fumihiro, Katoh, Shinsuke, Tanaka, Hirotaka, Maeda, Takeshi, Furusawa, Kazunari, Richardson, Mary, Kakehi, Yoshihiro, Kikumori, Kunika, Kuroha, Masanori
Publicado 2023